← Leaderboards
Kevin Urdahl
Seattle Children'S Hospital
$86,597,961
Attributed
$86,597,961
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $15.3M · FY2019–25$20M$15M$10M$5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$86,597,961 · 1
By mechanism
N01$86,597,961 · 1
Top collaborators
No co-investigators on record.
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- D. Noah Sather$18,678,273
- Donald L Sodora$27,419,798
- Marion Pepper$10,668,571
- Kenneth D Stuart$53,231,777
- Rafael E Hernandez$1,366,368
Others in their field
Other Emerging Leaders on “Tissues”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$61,115,130
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,559,980
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$33,867,067
- Lynn Briscoe · Leidos Biomedical Research, Inc.$29,633,515
Research focus
TissuesProgramsResearch PersonnelImmuneImmune ResponseImmune TargetingImmunologicsTuberculosis VaccinesTuberculosisMultidisciplinaryMycobacterium TuberculosisAnimalsNonhuman PrimateResponseVaccine StrategyDesignHiv SeronegativityHiv SeropositivityHuman SubjectNon-Tuberculosis MycobacteriaImmune EvasionMycobacterium InfectionsVaccine-Induced ImmunityResearch Activity
Grant awards (13)
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)$4,805,147
N01 · FY2025 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$9,482,062
N01 · FY2024 · AI · contact PI
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)$5,443,065
N01 · FY2024 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$378,109
N01 · FY2024 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$10,725,373
N01 · FY2023 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER$3,592,425
N01 · FY2023 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$9,211,989
N01 · FY2022 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - DMID$3,466,221
N01 · FY2022 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$923,533
N01 · FY2022 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$13,001,420
N01 · FY2021 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$11,541,977
N01 · FY2020 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH$554,910
N01 · FY2020 · AI · contact PI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$13,471,730
N01 · FY2019 · AI · contact PI